000			02007 a2200505 4500
005			20250515130930.0
264		0	_c20081210
008			200812s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2008.06.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aSciot, Raf
245	0	0	_aDistribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cSep 2008
300			_a1855-60 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650	0	4	_aAntigens, CD34 _xmetabolism
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBenzamides
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aExons
650	0	4	_aFemale
650	0	4	_aGastrointestinal Stromal Tumors _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMutation _xgenetics
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aProto-Oncogene Proteins c-kit _xgenetics
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aReceptor, Platelet-Derived Growth Factor alpha _xgenetics
700	1		_aDebiec-Rychter, Maria
700	1		_aDaugaard, Soren
700	1		_aFisher, Cyril
700	1		_aCollin, Francoise
700	1		_avan Glabbeke, Martine
700	1		_aVerweij, Jaap
700	1		_aBlay, Jean-Yves
700	1		_aHogendoorn, Pancras C W
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 44 _gno. 13 _gp. 1855-60
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2008.06.003 _zAvailable from publisher's website
999			_c18132779 _d18132779